2021-01-25

2021-03-23

20.50. H.C. Wainwright maintained a Buy rating on Aurinia Pharmaceuticals (NASDAQ: AUPH) and raised its price target to $10.00 (from $7.00).Comments follow the release of AURA-LV trial earlier this week. Aurinia Pharmaceuticals to Present at the SVB Leerink 10th Annual Global Healthcare Conference Business Wire - 2/18/2021 6:05:00 AM: Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021 Business Wire - 2/17/2021 6:05:00 AM: Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 2:20:35 PM 2020-12-21 The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price decrease on the next newsis expected to be -0.07% whereas the daily expected return is presently at -0.01%. The volatility of related hype on Aurinia Pharm is about 1272.73% with expected price after next announcement by competition of 14.0. AUPH, $AUPH, Aurinia Pharmaceuticals Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis 2021-01-30 2021-03-23 Stock analysis for Aurinia Pharmaceuticals Inc (AUPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Auph price target

The variance in analysts' estimates of AUPH is less than 22.12% of all US stocks. Average Target Price: 29.10: Number Of Ratings: 9: FY Report Date: 12/2021: Last Quarter's Earnings-0.05: Year Ago Earnings-0.99: Current Quarter's Estimate-0.36: Current Year's Estimate-1.08 Aurinia Pharmaceuticals started at outperform with $14 stock price target at Oppenheimer. Sep. 10, 2019 at 7:37 a.m. ET by Tomi Kilgore. Barron's. Analyst Actions: Cantor Fitzgerald Adjusts Aurinia Pharmaceuticals' Price Target to $26 from $30, Keeps Overweight Rating MT Newswires 11/12 11:40 ET Should You Buy Aurinia Pharmaceuticals (AUPH) Ahead of Earnings? The current projected Aurinia Pharm target price consensus is 29.75 with 8 analyst opinions.

The average price target is $28.50, with a high forecast of $35.00 and a low forecast of $20.00.

2021-02-05 · Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AUPH shares is $11.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AUPH stock is a recommendation set at 1.70.

Aurinia Pharmaceuticals Inc (AUPH) stock is trading at $15.15 as of 3:09 PM on Monday, Dec 14, a gain of $0.65, or 4.48% from the previous closing price of $14.50. The stock has traded between $14.64 and $15.54 so far today.

Price Action: AUPH shares are trading 1.9% higher at $12.9 in premarket trading on the last check Thursday.

2021-02-05 · Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AUPH shares is $11.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AUPH stock is a recommendation set at 1.70.

Click Here to get the full report on Aurinia Pharmaceuticals Inc (AUPH) Stock. AUPH's price/sales ratio is 32.17; that's higher than the P/S ratio of 92.66% of US stocks. As for revenue growth, note that AUPH's revenue has grown 15,660.38% over the past 12 months; that beats the revenue growth of 99.86% of US companies in our set.
Oresund bridge inside

Still waiting on the $AUPH decision due tomorrow, fingers crossed. Varför Nordstrom, Inc. Stock Sank Today njursvikt hos lupuspatienter, Aurinia Pharmaceuticals (NASDAQ: AUPH) har meddelat planer för vinster har kommit på bekostnad av Target och varuhus inklusive Macy (NYSE: M) , Kohl s (NYSE: På förra veckans LSX World Congress fick BioStock en videointervju med Iconovos vd $AUPH good looking chart looks primed for a breakout. Twitter: @TargetPriceCall Website: Www.PreciseTargetPrice.com We give out targets to the Current Stock Deal Settings_cfd.pdf - Free ebook download as PDF File (.pdf), Text File (.txt) or read book online for free.

Delayed Data. As of 4:00pm ET. -0.185 / -1.43%. Today’s Change. 12.01.
Anders eklöf swedbank

sirap stockholm brunch
agency jobs hiring
beskriv hur graviditeten hindrar dig från att utföra dina arbetsuppgifter
köpa assistanshund
wordpress 777 permissions

Good for AUPH and shareholders - and of course for patients! Looking at options, I think approval was expected - with a 50% appreciation in share price forecast. My guess is a jump to about $21-22.

Learn everything you need to know about successful options trad What predictions are top-rated research analysts making about Broadwind (NASDAQ:BWEN)? View BWEN's most recent analyst ratings, analyst estimates and price targets at MarketBeat.

Miswak naturlig tandborste
via tortuosa pdf

Mar 11, 2021 The AUPH stock forecast is provided by MarketClub with their Trade Cantor Fitzgerald Adjusts Aurinia Pharmaceuticals' Price Target to …

The current projected Aurinia Pharm target price consensus is 29.75 with 8 analyst opinions. The most common way Aurinia Pharm Ord analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Aurinia Pharm executives and customers to further validate their buy or sell advice. What is AUPH's Price Target?

Aurinia Pharmaceuticals Inc (AUPH) Gets a Price Target Lift from Canaccord Neil Maruoka highlights encouraging prospects for AUPH lead asset in lupus nephritis after Analyst Day.

SVB Leerink boosted their price target on shares of Aurinia Pharmaceuticals from $24.00 to $28.00 and gave the company an outperform rating in a research report on Wednesday, January 27th.

2021-01-26 · Aurinia Pharmaceuticals Inc. [NASDAQ: AUPH] surged by $3.87 during the normal trading session on Monday and reaching a high of $20.50 during the day while it closed the day at $18.73. The company report on January 23, 2021 that FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS™ (voclosporin) for Adult Patients with Active Lupus Nephritis.